BASF shuts ibuprofen production at US plant due to technical problem

Written by Ruby Khatun Khatun Published On 2018-06-30T09:30:13+05:30 | Updated On 30 Jun 2018 9:30 AM IST

FRANKFURT: German chemicals group BASF has shut down production of ibuprofen at its plant in Bishop, Texas because of a technical problem, a spokesman for BASF said.

The spokesman said it could take until early September to fix the problem at the plant, where ibuprofen production has been shut down since June 3.

He gave no further details of the nature of the technical issue but said a more detailed analysis should be available next month.

BASF last year announced plans to invest around 200 million euros ($232.74 million) in a new ibuprofen plant at its headquarters in Ludwigshafen in Germany and to expand the Bishop site’s production capacity.

It said at the time that the investment would make it the only company worldwide making ibuprofen at more than one plant. The new facility in Germany is scheduled to come online in 2021.

Trade publication Apotheke Adhoc, which first reported the shutdown, said the Bishop site has a capacity of 5,000 tonnes per year, accounting for around a sixth of the world’s ibuprofen supply.

(Reporting by Maria Sheahan. Editing by Jane Merriman)

BASFBishopibuprofenproductionshutstechnical problemTexasUS plant

Source : REUTERS

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Ruby Khatun Khatun